Last reviewed · How we verify
NCT05380895
Comparison of Daytime Surgery in Varicose Veins Patients With and Without Superficial Venous Thrombosis
trial in Varicose Veins in 699 participants. Status unknown.
10 June 2024
Quick facts
| Lead sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 699 |
| Start date | 10 June 2022 |
| Primary completion | 10 June 2024 |
| Estimated completion | 10 June 2025 |
| Sites | 1 location across China |
Conditions studied
- Varicose Veins — all drugs for Varicose Veins →
- Superficial Venous Thrombosis — all drugs for Superficial Venous Thrombosis →
- Day Surgery — all drugs for Day Surgery →
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Who can join
Adults 18 to 75, any sex, with Varicose Veins or Superficial Venous Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Varicose veins of lower extremities are the most common disease in vascular surgery, and daytime surgery has gradually become the mainstream of varicose veins of lower extremities. Superficial venous thrombosis is one of the common complications of varicose veins of lower limbs. Current consensus is that patients with superficial venous thrombosis should be treated with standardized anticoagulant therapy to prevent their progression to venous thrombotic disease.SVT patients need standardized anticoagulant therapy for a period of time, while DS is current mainstream treatment of VV. Will the existence of SVT affect the safety and efficacy of DS of VV, leading a need of changing the treatment strategy and carrying out anticoagulant treatment for SVT before DS on VV patients? To date, there is no research on this issue. Therefore, we conducted this study to comprehensively evaluate the safety, feasibility, perioperative and long-term efficacy of DS in VV patients complicated with SVT, and systematically compared patients who had VV only.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of day surgery between varicose veins with and without superficial venous thrombosis below knee: a propensity score-matched analysis.
Xu J, Xu X, Tian J, Huang M, et al · · 2023 · cited 1× · PMID 37537563 · DOI 10.1186/s12872-023-03398-2
Verify or expand the search:
- PubMed search for NCT05380895
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Varicose Veins
Currently open trials in the same condition.
- NCT07449728 — The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression · NA · recruiting
- NCT06971068 — Vacuum-assisted Laser Ablation (VALA) for Treatment of Large Saphenous Veins · NA · recruiting
- NCT05735639 — THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) · Phase 4 · recruiting
- NCT05410912 — Varicose Vein in Patients Under the Age of 40 · active not recruiting
- NCT04231942 — Elastic Compression Stockings and Varicose Veins Recurrence · NA · active not recruiting
Other Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University trials
Trials by the same sponsor.
- NCT07168083 — Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression · not yet recruiting
- NCT07413497 — A Prospective Observational Clinical Study on Exploring the Value of Surgical Excision Combined With 32P Application in · not yet recruiting
- NCT07461077 — Noninvasive Implantation Potential vs Morphology-Based Selection in IVF Single Blastocyst Transfer · NA · not yet recruiting
- NCT07533526 — Effects of Instrument-Assisted Constant-Speed Injection Versus Manual Injection on Pain From Large-Volume Subcutaneous I · NA · not yet recruiting
- NCT07408648 — A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05380895 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Last refreshed: 19 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05380895.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing